Analgesic and pulmonary effects of continuous intercostal nerve block following thoracotomy
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s~e chaque six heures d double insu, 20 patients post-thoracotoraie ont ~td divis~s afin de recevoir quatre doses de soit : 20 ml 0,5% de bupivacai'ne avec ~pin~phrine 5 tzg.ral -t (groupe bupivacai'ne, n = 10), ou 2O ral de solutd physiologique sans pr~servatif (groupe placebo, n = I0) via un catheter intercostal chaque six heures. Les patients recevant des injections de bupivacai'ne intercostal ont ddmontr~ une plus grande diminution dans le test du ~ Visual analogue pain scores (VAS) (P < 0.05) ,~ et ont requis en 24 heares raoins de morphine, 16,6 + 4,6 rag vs 35,8 +-7,2 rag que lespatients du groupeplacebo (P < 0.05). Les valeurs post-injection plus dlev~es dtaient hordes dans le FEVt, la capacit~ vitale forcde et le flot expiratoire maximal pour le groupe bupivacai'ne (P < 0.01). L'administration r~p~t~e de bupivacai'ne intercostale a amend une accumulation syst~raique mais le niveau maximal de bupivacai'ne apr~s 400 rag ~tait bas d 1.2 +-0,2 lxg' ral -t . Ainsi. la technique du bloc nerveax intercostal continu d~crite dans cette ~tude fut un moyen thdrapeutique efficace pour le contr6le de la douleur post-thoracotomie.
For many years before the use of spinal opioids, intercostal nerve block was the standard of effective regional analgesia following thoracotomy incisions.t'2 Its populaxity continues because it is simple to perform, and lacks many of the potential side-effects of spinal opioids: respiratory depression, pruritus and urinary retention. Although effective, analgesia after a single intercostal nerve block is limited by the duration of the local anaesthetic activity. To achieve prolonged pain relief, a percutaneous continuous intercostal nerve block technique has been described. 3 This technique has been applied effectively to control pain following upper abdominal incisions, 4 sternotomy, 5 rib fractures 3,6 and thoracotomy. 7 In the case of thoracotomy incision, it is conceivable that a simple intrathoracic approach to posterior intercostal catheterization be used as the thoracic cavity is open to direct inspection. Among the regional blocks commonly practiced, intercostal nerve block results in the highest systemic local anaesthetic absorption. With the continuous injection technique, the potential for local anaesthetic toxic reaction needs to be addressed.
The purpose of this study was to examine the usefulness of an alternative intrathoracic method of continuous intercostal nerve block in the control of post-thoracotomy pain, its effect on postoperative lung function and the degree of systemic bupivacaine accumulation after repeated intercostal injections.
Methods
Twenty ASA physical status I1 and III patients, aged 44-81 yr, gave informed consent to participate in this prospective double-blind study, as approved by the Human Research Committee of Toronto Western Division, The Toronto Hospital. Patients with known local anaesthetic hypersensitivity, renal and hepatic diseases, were excluded. Elective thoracotomies were performed by the same thoracic surgeon for the following procedures: Iobectomy (n = 13), wedge resection (n = 2) and trans-thoracic oesophageal surgery (n = 5). All thoracotomy incisions were made in the posterior fifth intercostal spaces, starting at the axilla and ending at the midpoint between the scapula and thoracic spine. All patients received genera] anaesthesia: premedication with 5-I0 mg diazepam one hour before surgery, induction with thiopentone, intubation with double lumen tube following succinylcholine and maintenance with pancuronium, nitrous oxide, oxygen and a volatile inhalational agent (isoflurane or enflurane). Intraoperative fentanyl administration was limited to 2 ~g.kg -I at the time of skin incision and then 1 Ixg'kg -I every hour as necessary, judged by the patient's haemodynamic response to surgical stimulation. Intraoperative monitoring included radial arterial catheter for blood pressure and blood gas measurements, ECG, pulse oximeter, temperature, peripheral nerve stimulator and mass spectrometer indicating endtidal carbon dioxide.
At the completion of the surgical procedure and before wound closure, the surgeon gently peeled back the parietal pleura from the ribs at the incision site. A 20-gauge Portex epidural catheter was tunnelled subpleurally under direct vision, 7-8 cm lateral to the vertebral column. The catheter was placed perpendicular to the ribs and 4-5 cm deep to reach a posterior intercostal space just below the incision site ( Figure I ). In the same manner, a second intercostal catheter was placed just above the incision site. The final position of the two catheters in the posterior intercostal spaces was verified both visually and by palpation. The remaining portion of each catheter was then loosely sutured in place on the parietal pleura before making their exits through the chest Mean -+ SEM.
wall near the chest tube site. The extra-thoracic ends were used for repeated intercostal injections.
In this double-blind protocol, patients were randomly assigned to one of two groups: bupivacaine or placebo group. Ten patients in the bupivacaine group received 100 mg of 0.5% bupivacaine with 1/200,000 epinephrine, i.e., 10 ml through each of the two catheters over two to three minutes after a negative aspiration test for blood. Patients, nurses, anaesthetists and investigators were all blinded to the type of solution for injection. For the placebo group, 10 ml of preservative-free saline were injected into each catheter. All patients were awake, extubated and monitored in the intensive care unit during injections. Three subsequent top-up doses, using the same dose and solution, were given to each group at six hourly intervals for 24 hr. A total of 400 mg bupivacaine was given in the bupivacaine group. Postoperative patient monitoring of systolic and diastolic blood pressure, heart rate, and respiratory rate was carded out every hour for the first eight hours and, in particular, vital signs were checked every ten minutes for 30 min after each intercostal injection.
Serial assessments of pain intensity and pulmonary function were initiated following the first intercostal injection. Assessments were not performed prior to the first intercostal injection because a lack of patient cooperation was anticipated during the immediate postanaesthetic period when patients awoke with intense pain. In each patient, visual analogue pain scores (VAS: 10 cm line with the left end labeled "No pain" and the right end labeled "Severe pain") were evaluated ten minutes before and one hour after each subsequent injection. Bedside pulmonary function tests of forced expiratory volume in one second (FEV 0, forced vital capacity (FVC) and peak expiratory flow rate (PEFR) by a portable compact spirometer (Vitalograph Ltd., Buckingham, England) were carded out in each patient at a 45" sitting angle preoperatively, one hour before and one hour after each injection.
To guarantee satisfactory analgesia, patients were instructed to request supplemental intravenous morphine from nurses who would administer repeated doses of 0.06 mg'kg -I every 15-30 min upon request. Details of morphine utilization in 24 hr were recorded and compared between the two groups. No other sedative medications were permitted.
Arterial blood in 3 ml aliquots, was obtained from indwelling radial artery catheters in 18 patients at 0, 2.5, 5, 10, 20 and 60 min after each of the four injections. Blood samples were centrifuged immediately to separate the plasma which was then frozen at -20 ~ C. To assess the extent of local anaesthetic systemic absorption, the bupivacaine concentration was determined in blood samples of nine patients by gas chromatography, a Plasma bupivacaine concentration is reported as p,g bupivacaine HCI. ml -~. The coefficient of variation of this assay was 10% at 0. I I~g' ml-~ and 5% at 1.00 p,g. ml-I. Mean peak bupivacaine concentration (Cma~,) and mean time to peak concentration (Tmax) were calculated.
Statistical analysis
Data are presented as mean values _+ SEM. Continuous variables, i.e., visual analogue pain score, pulmonary function tests, morphine consumption and plasma bupivacaine concentration were compared within and between groups using Student's t tests, one way analysis of variance (ANOVA) for repeated measures and multiple regression analysis where appropriate. Discrete variables were analyzed using Chi square tests. A P value of 0.05 or less was considered statistically significant.
Results
No significant differences were noted between the two groups in age, sex, height, weight, duration of surgery and intraoperative fentanyl dosage (Table I ). In the bupivacaine group, there were seven single Iobectomies, one wedge resection and two thoracotomies without lung resection (oesophageal surgery), in the placebo group, there were five single Iobectomies, one wedge resection and four thoracotomies without lung resection. In both groups, the degree of lung resection was comparable. Also, the time elapsed from the end of surgery to the first intercostal injection was not different, in the bupivacaine group 16.9 -14.9 min from the placebo group 24.4 __. 9.2 min.
Pain scores and morphine use
One hour after the first intercostal injection, both groups of patients showed high VAS pain scores (7.0 -0.8 in bupivacaine group versus 8. I _-. 0.6 in placebo group). Nevertheless, morphine requirement was less in the bupivacaine group following the first injection, 5.7 _ 2.7 mg (range: 0-28) versus 15.1 -3.4 mg (range: 2-33) in the placebo group (P < 0.05) (Figure 2 ). Two patients in the bupivacaine group did not require any supplemental morphine. Following the second, third and fourth injections, patients in the bupivacaine group showed a marked decline in their pain score by 50% or more (P < 0.05, Table 11 ). This degree of analgesic response was not noted in the placebo group. Furthermore, the 24 hr morphine requirement in the bupivacaine group was lower, a mean dose of 16.6 -4.6 mg (range: 0 -4 3 ) versus 35.8 • 7.2 mg (range: 10-8 I) in the placebo group (P < 0.05) (Table  1II) . Table IV) .
Postoperative pulmonary function assessment
The FVC and PEFR in the bupivacaine group decreased to 57. I -8.2% and 30.7 • 6. I% of preoperative values while the decline in the placebo group was 37. I • 8. I% and 28.2 • 9.1% respectively. Higher FVC and PEFR values were also found following the second and third bupivacaine intercostal injection (P < 0.05, Table IV) .
Plasma bupivacaine concentrations
Systemic accumulation of bupivacaine after repeated intercostal injections is demonstrated in Figure 3 . The rapid rise in plasma bupivacaine level peaked within 10-20 min (Tmax) of each intercostal administration. Mean peak levels (Cm~,) following each successive injection were: 0.5 • 0. I, 0.6 +--0. I, 0.9 • 0. I, and 1.2 -0.2 p,g.ml -t. After a total of 400 mg in 24 hr, the ICI = Intercostal injection; Pre = I hour pre-injection, Posl = I hour post injection. Mean 9 SEM. 9 P < 0.05, significant difference between groups in post-injection tests.
plasma bupivacaine level was still below toxic range (4 p,g. ml-I). 9 No cardiovascular or neurological complication as a result of intercostal bupivacaine injection was noted in this study.
Discussion
To maintain effective long-lasting analgesia, conventional intercostal nerve block needs to be repeated. Each time this is accompanied by the discomfort of patient positioning and multiple needle punctures at intercostal spaces adjacent to the incision site. In practice, a continuous technique allows repeated local anaesthetic administration without undue patient trauma and discomfort. For non-thoracotomy incisions, a blind percutaneous technique is used to insert an intercostal catheter (epidural catheter) into a single posterior intercostal space. 4 Despite initial controversy of the extent of local anaesthetic spreading within the intercostal space after a bolus injection, io the accumulated evidence has now confirmed that anaesthesia and analgesia can be achieved in multiple dermatomes following a 20 ml bolus injection at a single intercostal level.J ~-~3 Spreading of local anaesthetic following a bolus injection may be achieved via the subpleural, para-vertebral or epidural spaces. For thoracotomy incisions, this situation is unique in that a catheter can be placed, under direct vision, into the desired intercostal space with precision and with minimal trauma before chest wall closure. In our experience, this simple procedure can be accomplished within 5-lO min. Correct placement into the posterior intercostal spaces can be confirmed by visual inspection and by palpation. Using this technique, unintentional subarachnoid injection is unlikely because catheters are placed 7-8 cm from the posterior midline. Intercostal catheterization has advantages over interpleural catheterization. There is no diffusion barrier, parietal pleura, for the local anaesthetic agent to overcome. In addition, local anaesthetic has direct access to the intercostal nerves without being diluted by fluids in the pleural cavity.
Successful analgesia from this method of intercostal catheterization appears to depend on two factors: the ease of catheter insertion and the integrity of the parietal pleura under which the catheter is tunnelled. Unfavourable factors such as pleural adhesions preclude proper access to the posterior intercostal spaces and torn parietal pleura allows local anaesthetic leakage from the injection sites. Analgesic failure due to torn parietal pleura has been described. 14 Although the technique of continuous intercostal nerve block to control post-thoracotomy pain has been previously described, t4.16 detailed objective assessments on analgesic response and postoperative pulmonary function have been lacking. Also, in these previous studies, there were variations in the number of catheters placed (from one to four), in the choice of local anaesthetic (bupivacaine or lidocaine) and in the injection technique (intermittent bolus versus continuous infusion). In the present study, we chose to place two intercostal catheters, one above and one below the incision site. This was based on the assumption that the spread of local anaesthetic across the incision site may be unreliable.
Despite a small sample size of 20 patients, the analgesic effect of continuous intercostal nerve block to control post-thoracotomy pain was clearly demonstrated. Following bupivacaine, decreases in VAS and morphine requirement were highly significant. The reason for high VAS score one hour after the initial bupivacaine injection is unclear. However, analgesia from the initial dose was no doubt effective because the need for supplemental morphine during this period was less (Figure 2) .
Although effective, analgesia appeared to be incomplete since morphine supplementation was given to most patients in the bupivacaine group. Our results did not show the same degree of success as in Sabanathan's study which reported complete analgesia in 93% (75/81) of patients for 24 hr. n4 Unfortunately, the pain score was not documented in that study. There are several possible explanations for the incomplete analgesia and morphine supplementation in our patients: (I) Intercostal nerve block does not intercept all components of postthoracotomy pain: unblocked pain impulses may arise from diaphragmatic pleura which is innervated by the phrenic nerve, the mediastinum which is innervated by the vagus nerve, and damaged muscular and ligamentous structures in the periscapular, paravertebral side of the thoracotomy incision which is innervated by the posterior division of the appropriate spinal nerve. 17 (2) The double-blind design did not forbid narcotic supplementation in either patient group. Our results showed striking similarity in the amount of supplemental morphine required in the treatment and placebo groups as reported in Shulman's double-blind study on epidural morphine for post-thoracotomy pain.~8 (3) A difference in dose and technique of bupivacaine administration: intermittent injection of 100 mg at six hourly intervals in this study versus continuous infusion of a higher dose, 25-35 mg. hr-' (150-210 mg per six hours).
Deterioration in pulmonary function following thoracotomy can be attributed in part to incisional pain, which induces splinting of intercostal muscles, 19.2o and in part to a loss of lung parenchyma from surgical resection. 2' By controlling incisionai pain, conventional intercostal nerve block has been shown to improve FEVn, 22 '23 FVC 22'24'25 and PEFR 23'24'26 following thoracotomy. However, one would not expect to see beneficial pulmonary effects to last beyond the duration of local anaesthetic activity from a single dose unless repeated injections are given. This study demonstrated clearly that prolonged analgesia and improved pulmonary function can be obtained from repeated bupivacaine injections through two indwelling intercostal catheters (Table IV) .
In this study, we chose regular intermittent bolus injections every six hours and not "on demand." The selection of 100 mg bupivacaine per intercostal injection was guided by results of several previous studies. 6''1"27 The duration of analgesia was found to be six to seven hours for cholecystectomy patients. 6 Among the regional blocks commonly practiced, intercostal nerve block results in the highest systemic absorption of local anaesthetic. In the absence of data on systemic accumulation after repeated injections, we were conservative in restricting the 24 hr bupivacaine administration to 400 mg for fear of potential toxic drug reactions. For a 100 mg dose of bupivacaine with epinephrine injected intercostally, the plasma concentration reached a peak of 0.82 tzg. ml-n in 5-10 rain. 2a In this study, we found a slightly lower concentration 0.5 "+ O. 13 izg 9 ml-n after the initial 100 mg bolus. Even after the fourth bolus, the peak level was 1.2 +-0.2 Izg" ml -I which is lower than the toxic threshhold (4 izg. ml-n). 9 We did not observe any cardiovascular or neurological side-effect from this technique of continuous intercostal bupivacaine administration.
We conclude that continuous intercostal nerve block by repeated bupivacaine injections following thoracotomy offers satisfactory pain relief, improvement in pulmonary function, and safe, non-toxic plasma bupivacaine concentrations. However, the long-term efficacy and safety of this technique beyond 24 hr of treatment needs further elucidation.
